enVVeno Medical Corporation (NVNO)

NASDAQ: NVNO · IEX Real-Time Price · USD

4.620

-0.160 (-3.35%)

At close: Apr 19, 2024, 4:00 PM

4.790

+0.170 (3.68%)

After-hours: Apr 19, 2024, 7:50 PM EDT

enVVeno Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-23.52	-24.67	-16.53	-9.74	-7.63	-16.35	-8.25	-3.73
Depreciation & Amortization	0.55	0.53	0.45	0.38	0.4	0.13	0.14	0.15
Share-Based Compensation	5.2	8.99	6	0.88	0.94	1.92	0.88	1.51
Other Operating Activities	-1.08	-0.47	-1.77	0.19	0.39	4.63	2.57	-1.69
Operating Cash Flow	-18.86	-15.62	-11.85	-7.68	-5.9	-6.36	-4.2	-3.42
Capital Expenditures	-0.03	-0.12	-0.37	-0.18	-0.36	-0.01	-0.01	-0
Acquisitions	0	0	0	0	0	0	0.22	0
Change in Investments	-7.84	-34.44	0	0	0	0	0	0
Other Investing Activities	-	-	-	-	-	-	-0.04	-0.37
Investing Cash Flow	-7.87	-34.55	-0.37	-0.18	-0.36	-0.01	0.17	-0.37
Share Issuance / Repurchase	25.79	0	57.61	13.4	5.64	7.66	0	0
Debt Issued / Paid	0	0	0	0.31	0	2.08	2.98	0
Other Financing Activities	-	-	-	1.36	-	-0.71	1.08	2.26
Financing Cash Flow	25.79	0	57.61	15.07	5.64	9.03	4.06	2.26
Net Cash Flow	-0.94	-50.17	45.39	7.22	-0.62	2.66	0.02	-1.53
Free Cash Flow	-18.89	-15.73	-12.22	-7.86	-6.26	-6.37	-4.21	-3.42
Free Cash Flow Margin	-	-	-	-	-20037.42%	-3413.66%	-998.12%	-435.24%
Free Cash Flow Per Share	-1.54	-1.40	-1.41	-6.08	-9.93	-17.00	-17.19	-14.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).